BA
LLY icon

Ballew Advisors’s Eli Lilly LLY Stock Holding History

Ballew Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+170
New +$174K 0.11% 123

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ballew Advisors's LLY Position: Q2 2026 in Review

Ballew Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 170 shares worth $207K. The stake represents 0.11% of the portfolio and ranks #123 among its holdings.

4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ballew Advisors held 170 shares of Eli Lilly worth $207K as of Q2 2026.
  • Eli Lilly was a new Ballew Advisors position in Q2 2026.
  • Eli Lilly made up 0.11% of Ballew Advisors's portfolio in Q2 2026, its #123 holding.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ballew Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.